Class II · Moderate risk Ongoing
DOBUTamine Injection
Reason Discoloration; discolored solution from cracked vials
DOBUTamine Injection
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Discoloration: Firm received complaints of product discoloration and particulates.
What was recalled
DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV Use Only, Must be Diluted Prior to Use, (12.5 mg per mL), Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2025-20
- Recalling firm
- Hospira Inc.
- NDC code
- 0409-2025-20
- Origin
- IL, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1500-2016
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Dobutamine recalls
See all
Class II · Moderate risk Terminated
Dobutamine
Reason Lack of sterility assurance
Class II · Moderate risk Terminated
Dobutamine 2000 mcg/mL in a) D5W-500 mL
Reason Lack of Sterility Assurance.
Class II · Moderate risk Terminated
DOBUTAMINE HCL in D5W
Reason Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Class II · Moderate risk Terminated
Dobutamine various strengths in dextrose
Reason Lack of sterility assurance.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.